BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/30/2025 7:07:09 AM | Browse: 0 | Download: 0
Publication Name World Journal of Clinical Cases
Manuscript ID 112505
Country United States
Received
2025-07-29 11:23
Peer-Review Started
2025-07-29 11:23
To Make the First Decision
Return for Revision
2025-08-06 10:46
Revised
2025-08-07 02:45
Second Decision
2025-09-09 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-09-09 03:51
Articles in Press
2025-09-09 03:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-10-14 03:27
Publish the Manuscript Online
2025-10-30 07:07
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Letter to the Editor
Article Title Endogenous modulators in lung cancer
Manuscript Source Unsolicited Manuscript
All Author List Namra Patel, Viral Patel and Salim Surani
ORCID
Author(s) ORCID Number
Namra Patel http://orcid.org/0009-0009-4714-0493
Viral Patel http://orcid.org/0000-0002-6245-0299
Salim Surani http://orcid.org/0000-0001-7105-4266
Funding Agency and Grant Number
Corresponding Author Salim Surani, Department of Medicine and Pharmacology, Texas A&M University, 40 Bizzell Street, College Station, TX 77843, United States. srsurani@hotmail.com
Key Words Cyclooxygenase; Biomarkers; Angiogenesis; Tumor microenvironment; Thromboxanes; Prostaglandins; Nitric oxide; Lung cancer
Core Tip Endogenous mediators—nitric oxide, prostaglandin E₂, thromboxane A₂, and endothelins—induce lung tumor angiogenesis, immune escape, and metastasis through crosstalk signaling loops; targeting their individual receptors and employing eicosanoid biomarker profiles for patient stratification could enable more effective, patient-specific anti-inflammatory therapies in lung cancer.
Publish Date 2025-10-30 07:07
Citation <p>Patel N, Patel V, Surani S. Endogenous modulators in lung cancer. <i>World J Clin Cases</i> 2025; 13(31): 112505</p>
URL https://www.wjgnet.com/2307-8960/full/v13/i31/112505.htm
DOI https://dx.doi.org/10.12998/wjcc.v13.i31.112505
Full Article (PDF) WJCC-13-112505-with-cover.pdf
Manuscript File 112505_Auto_Edited_012130.docx
Answering Reviewers 112505-answering-reviewers.pdf
Audio Core Tip 112505-audio.mp3
Conflict-of-Interest Disclosure Form 112505-conflict-of-interest-statement.pdf
Copyright License Agreement 112505-copyright-assignment.pdf
Peer-review Report 112505-peer-reviews.pdf
Scientific Misconduct Check 112505-scientific-misconduct-check.png
Scientific Editor Work List 112505-scientific-editor-work-list.pdf
CrossCheck Report 112505-crosscheck-report.pdf